US EditionPublished • loading... • Updated
Ozempic's Rival Shoots 125% of the Pharmaceutical Sales Lilly
Summary by Confidencial Digital
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Launch with immediate impact The rise of the antidiabetic market in full expansion Direct competition with Novo Nordisk Beyond diabetes The pharmaceutical Lilly has fired 125.4% of its sales on the pharmacy channel in the last year, to reach 558 million euros, according to the latest market data prepared by the consultant IQVIA with closure in January 2026. Mounjaro unbanks Ozempic as a drug to lose weight more wanted on the internet The impulse…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
